{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:44:46Z","timestamp":1791139486544,"version":"4.1.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Background<\/jats:p>\n               <jats:p>Psoralen ultraviolet A (PUVA) and narrowband (NB)-UVB have been shown to be efficacious in the treatment of vitiligo. With large and repeated doses, UVA may lead to immediate skin darkening and to delayed tanning. Our previous experience with broadband (BB)-UVA in vitiligo showed encouraging results.<\/jats:p>\n               <jats:p>Aim<\/jats:p>\n               <jats:p>To test the efficacy of BB-UVA in vitiligo and to evaluate if it could provide an alternative treatment for this condition.<\/jats:p>\n               <jats:p>Methods<\/jats:p>\n               <jats:p>This prospective, randomized, controlled, comparative clinical trial enrolled 45 patients with vitiligo, who were randomly divided into three groups, with group A receiving UVA 15 J\/cm2\/session, group B receiving UVA 10 J\/cm2\/session, and group C receiving PUVA. The patients received three sessions\/week for 5 months, with 60 sessions in total.<\/jats:p>\n               <jats:p>Results<\/jats:p>\n               <jats:p>At the mid-point of treatment, clinical response was significantly higher in patients receiving PUVA than in the other two groups At the end of the study, clinical response was comparable for groups A and C (UVA 15 J\/cm2 and PUVA, respectively), and both were significantly higher than the group receiving UVA 10 J\/cm2. Patients in the PUVA group responded mainly with perifollicular pigmentation, whereas those receiving UVA responded mainly with lesional tanning.<\/jats:p>\n               <jats:p>Conclusions<\/jats:p>\n               <jats:p>BB-UVA at a dose of 15 J\/cm2\/session gives results for vitiligo that are comparable to PUVA, suggesting it might be useful when oral psoralens are contraindicated.<\/jats:p>","DOI":"10.1111\/ced.12099","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T07:22:54Z","timestamp":1364973774000},"page":"830-835","source":"Crossref","is-referenced-by-count":13,"title":["Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial"],"prefix":"10.1093","volume":"38","author":[{"given":"M.","family":"El Mofty","sequence":"first","affiliation":[{"name":"Phototherapy Unit Dermatology Department Cairo University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bosseila","sequence":"additional","affiliation":[{"name":"Phototherapy Unit Dermatology Department Cairo University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"Mashaly","sequence":"additional","affiliation":[{"name":"Phototherapy Unit Dermatology Department Cairo University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Gawdat","sequence":"additional","affiliation":[{"name":"Phototherapy Unit Dermatology Department Cairo University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Makaly","sequence":"additional","affiliation":[{"name":"Phototherapy Unit Dermatology Department Cairo University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,12,1]]},"reference":[{"key":"2023012703534566800_ced12099-bib-0001","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autrev.2006.09.010","article-title":"Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo","volume":"6","author":"Kemp","year":"2007","journal-title":"Autoimmun Rev"},{"key":"2023012703534566800_ced12099-bib-0002","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1091\/mbc.11.8.2543","article-title":"The tumor suppressor p53 can both stimulate and inhibit ultraviolet light-induced apoptosis","volume":"11","author":"McKay","year":"2000","journal-title":"Mol Biol Cell"},{"key":"2023012703534566800_ced12099-bib-0003","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2006.01413.x","article-title":"Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo","volume":"20","author":"Parsad","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023012703534566800_ced12099-bib-0004","first-page":"15","article-title":"Current and emerging therapy for the management of vitiligo","volume":"12","author":"Border\u00e9","year":"2009","journal-title":"Clin Cosmet Investg Dermatol"},{"key":"2023012703534566800_ced12099-bib-0005","first-page":"147","article-title":"The mechanisms of action of phototherapy in the treatment of the most common dermatoses","volume":"2","author":"Bulat","year":"2011","journal-title":"Coll Antropol"},{"key":"2023012703534566800_ced12099-bib-0006","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0781.2006.00229.x","article-title":"Ultraviolet A in vitiligo","volume":"22","author":"El-Mofty","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2023012703534566800_ced12099-bib-0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.2006.07584.x","article-title":"Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo","volume":"156","author":"Wu","year":"2007","journal-title":"Br J Dermatol"},{"key":"2023012703534566800_ced12099-bib-0008","first-page":"35","article-title":"A comparative study between different ultraviolet modalities in the treatment of vitiligo","volume":"31","author":"El-Mofty","year":"2011","journal-title":"Egypt J Dermatol Androl"},{"key":"2023012703534566800_ced12099-bib-0009","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"Br Med J"},{"key":"2023012703534566800_ced12099-bib-0010","author":"Dawson","year":"2001"},{"key":"2023012703534566800_ced12099-bib-0011","first-page":"291","article-title":"Effect of UV-A, UV-B and psoralen on in vivo human melanin pigmentation","volume":"3","author":"Pathak","year":"1976","journal-title":"Pigment Cell"},{"key":"2023012703534566800_ced12099-bib-0012","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/jid.2010.95","article-title":"Impact of long-wavelength UVA and visible light on melanocompetent skin","volume":"130","author":"Mahmoud","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2023012703534566800_ced12099-bib-0013","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2008.10.031","article-title":"Cutaneous T-cell lymphoma in skin of color","volume":"60","author":"Hinds","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"2023012703534566800_ced12099-bib-0014","first-page":"55","author":"Luger","year":"1995"},{"key":"2023012703534566800_ced12099-bib-0015","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2004.07.063","article-title":"Photoprotection","volume":"52","author":"Kullavanijaya","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"2023012703534566800_ced12099-bib-0016","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1523-1747.ep12524813","article-title":"A new apparatus with high radiation energy between 320 and 460 nm. physical description and dermatological applications","volume":"76","author":"Mutzhas","year":"1981","journal-title":"J Invest Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12099","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/38\/8\/830\/46940980\/ced0830.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/38\/8\/830\/46940980\/ced0830.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T04:03:57Z","timestamp":1674792237000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/38\/8\/830\/6592049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,12,1]]},"published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.12099","relation":{},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"value":"1365-2230","type":"electronic"},{"value":"0307-6938","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,12,1]]},"published":{"date-parts":[[2013,12,1]]}}}